 |
인쇄하기
취소
|
Celltrion CEO’s stake sell-off plan yet to be finalized
Celltrion said Monday that the company has yet to finalize its plan to sell the entire controlling stake of Celltrion Chairman and CEO Seo Jung-jin to a multinational pharmaceutical company.
In a regulatory filing on Monday, Celltrion officials said that the company plans to sell his entire stake in Celltrion, Celltrion Healthcare Co. and Celltrion Pharm Inc., after the European Union gives ...
In a regulatory filing on Monday, Celltrion officials said that the company plans to sell his entire stake in Celltrion, Celltrion Healthcare Co. and Celltrion Pharm Inc., after the European Union gives ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.